SBIR/STTR Research Award

Ultra-micro oxygen sensor development

Award identifier f213d95f5056d9801cdc495f685705ca127cab577d693700905803c25c63b8fbAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$226,669

Program and phase

STTR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Biocurrents Research, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The overall aim of this STTR proposal is to take an innovative, successful; laboratory based technology and transfer it to the commercial sector. Specifically, we wish to establish the capabilities within the Company to manufacture reliable, robust and inexpensive ultra-micro oxygen sensors suitable for electrochemical applications related to cellular metabolism. These sensors will be specifically designed to operate under the exacting conditions of a non-invasive modulation technique for signal detection. This electrochemical technique allows the monitoring of chemical conditions in the extended boundary layer surrounding single cells and tissues. Currently there is no commercial provider of suitable oxygen sensors meeting the exacting design requirements of this application. We propose the following Specific Aims for Phase I. Specific Aim 1: To optimize the fabrication of the oxygen sensor design developed in the laboratory of the Principal Investigator for large-scale production. Specific Aim 2: Design and execute a series of tests to evaluate the performance criteria of the manufactured sensors, and validate the efficiency of oxygen sensors using techniques compatible with scaling up the test procedure. Aims 1 & 2 incorporate a significant effort towards developing semi-automated production. The commercial availability of the sensor will facilitate dissemination to research, clinical and pharmaceutical companies. We anticipate a broad market demand including research areas on metabolism - as applicable to diabetes, cancer, age related human infertility and other diseases of the mitochondrion. Further, other oxygen dependent cell events can be monitored, as in the oxidative burst of the macrophage immune response. Given the importance of metabolism to the pathology of diseases the availability of the new oxygen sensor will facilitate numerous biomedical investigations and provide a novel methodology for targeting drug development at the level of single cell assays.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.